🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A recent study by DCBSM researchers found a nearly two-fold increase in the risk of radiation necrosis among patients with brain metastases receiving immunotherapies within four weeks of radiosurgery. Read more: neurosurgery.duke.edu/news/therapy-c…

Palliative care is about providing relief and preventing suffering at any age or stage of illness. Palliative care experts partner with patients, their families, and their medical teams to meet your personalized goals.

Metastatic brain tumors are different than primary brain tumors. Not only are they more common, they're not actually brain cancer. The cancer is still the primary cancer - lung, breast, or others - but that cancer is now in the brain.

10-15% of people with stage IV breast cancer have brain metastases.

More than 60% of patients with advanced prostate cancer will eventually develop bone metastases. The spine is one of the most common places for bone metastasis.

Antibody-drug conjugates (ADCs) combine a monoclonal antibody and chemotherapy with a linking protein. The antibody will only bind to one substance which targets the chemotherapy to specific cancer cells, making healthy cell less likely to be harmed.

Researchers at Duke have found that breast cancer can enter the lining of the brain (leptomeninges) through bone marrow and emissary veins. Read more here: neurosurgery.duke.edu/news/duke-rese…

Cancer support services are about making sure patients are cared for as a whole person. At Duke, these services include supportive counseling, child life specialists, physical and occupational therapy, and palliative care. Learn more: dukehealth.org/locations/duke…

Almost any cancer can spread to the brain and spine, but some metastasize there more often. Lung, breast, prostate, melanoma, and colon cancer are among the more common.

Brain metastases are one of the most common complications of melanoma. More than 60% of stage IV melanoma patients will develop brain metastases.

SRS (stereotactic radiosurgery) uses high doses of radiation in precisely targeted areas to treat tumors, especially in delicate places like the brain. Learn more about SRS: dukehealth.org/treatments/ste…

Duke's April Salama, MD, and Lucy Boyce Kenndy, MD, of Cleveland Clinic published a review looking at how to choose therapies to treat metastatic melanoma. Read the review here: link.springer.com/article/10.100…

It's important for caregivers to take care of themselves, too. That means practicing self-care, but also recognizing burnout and when to ask for help.

Everything changed for Brian FitzGerald in an instant. After spending the summer looking for answers, one last scan kicked off a whirlwind of surgery and treatments for melanoma that had metastasized to his brain. Read his story here: neurosurgery.duke.edu/news/south-car…

About 15% of people with kidney cancer will develop brain metastases. It’s important for patients with to discuss any new neurological issues with their doctor.

Until about 10 years ago, patients with brain and spine metastases weren't eligible to participate in clinical trials. Today, we have trials designed specifically for these patients. Learn more about active trials here: neurosurgery.duke.edu/mets-resources

Thank you to Congresswoman Valerie Foushee for continuing to support brain and spine metastasis awareness. On Monday, Rep. Foushee reintroduced a resolution naming June Brain and Spine Metastasis Awareness Month. Read more: neurosurgery.duke.edu/news/foushee-r…

It takes a village to care for patients. Visit brainspinemetastasis.org to find patient resources and our partner organizations.

Like the brain, almost all cancers can spread to the bone but some are more likely than others. Breast, lung, prostate, kidney, melanoma, ovarian, and thyroid cancers are the most common. The spine is the most common site for bone metastases.

Our second #RadOnc Annual Report is out! This edition highlights several key milestones – the 20-year journey with Duke Medical Physics; the dept's central role in Duke Center for Brain and Spine Metastasis; success in the Lafata Lab; two decades of leadership from Dr. Willett; and more 🔗radonc.duke.edu/news/annual-re…